BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Sousa MJ, Gervaso L, Meneses-Medina MI, Spada F, Abdel-Rahman O, Fazio N. Cyclin-dependent Kinases 4/6 Inhibitors in Neuroendocrine Neoplasms: from Bench to Bedside. Curr Oncol Rep 2022. [PMID: 35262877 DOI: 10.1007/s11912-022-01251-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Wheless M, Das S. Systemic Therapy for Pancreatic Neuroendocrine Tumors. Clin Colorectal Cancer 2023;22:34-44. [PMID: 36114085 DOI: 10.1016/j.clcc.2022.08.003] [Reference Citation Analysis]
2 Karami Fath M, Azargoonjahromi A, Soofi A, Almasi F, Hosseinzadeh S, Khalili S, Sheikhi K, Ferdousmakan S, Owrangi S, Fahimi M, Zalpoor H, Nabi Afjadi M, Payandeh Z, Pourzardosht N. Current understanding of epigenetics role in melanoma treatment and resistance. Cancer Cell Int 2022;22:313. [PMID: 36224606 DOI: 10.1186/s12935-022-02738-0] [Reference Citation Analysis]